Stanford Cancer Institute News
CAR-T Cell Therapy in Solid Tumors
CAR-T therapy has shown a great benefit in patients with hematologic and lymphatic cancers. However, applying the therapy to solid tumors has proven to be challenging. One of the barriers is T cell exhaustion, where the CAR-T cell becomes dysfunctional.
Meryl Selig has had a unique experience at the Stanford Cancer Institute (SCI). She began as a patient volunteer in 2009 before being diagnosed with cancer and becoming a patient. She became one of the first patients to receive a novel chimeric antigen receptor (CAR-T) cell therapy when she enrolled in a phase-one clinical trial in 2023.
The Stanford Cancer Institute Early Drug Development program awarded for increasing clinical trial access
The Stanford Cancer Institute Early Drug Development (EDD) program brings in early-phase clinical trials so cancer patients can have access to innovative treatments that could provide a therapeutic benefit.
2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR
Stanford has 10 presenters at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR.
World Cancer Day: Stanford Cancer Researchers Drive Progress in Closing the Care Gap
In honor of the 2024 World Cancer Day theme, “Close the Care Gap,” we highlight a few Stanford cancer researchers working to close the care gap in diverse populations through screening, clinical trials, prevention, and community engagement.
Tumor Boards Improve Outcomes
The Stanford Cancer Institute has over a dozen tumor boards dedicated to identifying each patient's most effective cancer treatment and care strategy.
Navigating Challenges in Cervical Cancer Brachytherapy with TARGIT-FX
Stanford Cancer Institute member Elizabeth Kidd, MD, is developing new tools to facilitate the broader adoption of brachytherapy and ultimately improve outcomes for women facing cervical cancer.
Protecting the rights of cancer patients
On August 30, 2021, California adopted the Cancer Patients’ Bill of Rights, the first legislation of its kind in the United States. This legislation gives cancer patients inalienable rights to help them achieve access and equity in their care.
Lung Cancer Survivors Who Have Never Smoked Have a High Risk of Developing New Cancers
A study led by SCI members Summer Han, PhD, and Eunji Choi, PhD, and graduate student Chloe Su found that lung cancer survivors who have never smoked have the same risk as survivors who have smoked of developing secondary primary lung cancer (SPLC), which is cancer that spreads to the lungs from somewhere else in the body.
Gastrointestinal Cancer: A Conversation with George Poultsides, MD
During Gastric and Pancreatic Cancer Awareness Month, SCI member George Poultsides discusses his efforts to advance early detection of pancreatic cancer, improve personalized oncology, and direct Stanford's Surgical Oncology Fellowship program while enhancing patient-centered care.